Search Results

813 articles with title/keywords/abstract containing Angiotensin II 1 receptor antagonists

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

Synthesis and Biological Study of 3-Butyl-1-(2,6-dichlorophenyl)-1H-[1,2,4]triazol- 5(4H)-one Derivatives as Anti-hypertension Drugs

Authors: Zhang, Yanchun; Zhou, Jinpei; Pan, Weihong; Wu, Xiaoming; Wang, Shuai

Source: Letters in Drug Design & Discovery, Volume 7, Number 1, January 2010 , pp. 18-22(5)

Publisher: Bentham Science Publishers

Treatment Strategies to Minimize or Prevent Chronic Allograft Dysfunction in Pediatric Renal Transplant Recipients: An Overview

Authors: Höcker, Britta; Tönshoff, Burkhard

Source: Pediatric Drugs, Volume 11, Number 6, 1 December 2009 , pp. 381-396(16)

Publisher: Adis International

Effect on the Atherogenic Marker Plasminogen Activator Inhibitor Type-1 of Addition of the ACE Inhibitor Imidapril to Angiotensin II Type 1 Receptor Antagonist Therapy in Hypertensive Patients with Abnormal Glucose Metabolism: A Prospective Cohort Study in Primary Care

Authors: Yajima, Ken; Shimada, Akira; Hirose, Hiroshi; Oikawa, Yoichi; Yamada, Satoru; Meguro, Shu; Irie, Junichiro; Irie, Seiko

Source: Clinical Drug Investigation, Volume 29, Number 12, 1 December 2009 , pp. 811-819(9)

Publisher: Adis International

Antagonist of the Type-1 ANG II receptor prevents against LPS-induced septic shock in rats

Authors: Hagiwara, Satoshi; Iwasaka, Hideo; Hidaka, Seigo; Hasegawa, Akira; Koga, Hironori; Noguchi, Takayuki

Source: Intensive Care Medicine, Volume 35, Number 8, August 2009 , pp. 1471-1478(8)

Publisher: Springer

Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats

Authors: Russell, JC; Kelly, SE; Vine, DF; Proctor, SD

Source: British Journal of Pharmacology, Volume 158, Number 6, November 2009 , pp. 1588-1596(9)

Publisher: Blackwell Publishing

Adherence to Antihypertensive Medications: A Review and Update

Authors: >Francesco Vittorio Costa,; D'Ausilio, Anna; Bianchi, Cosetta; Negrini, Cristina; Lopatriello, Stefania

Source: High Blood Pressure & Cardiovascular Prevention, Volume 16, Number 3, 1 September 2009 , pp. 101-110(10)

Publisher: Adis International

Effects of AT1- and β-adrenergic receptor antagonists on TGF-β1-induced fibrosis in transgenic mice

Authors: Seeland, U.; Schäffer, A.; Selejan, S.; Hohl, M.; Reil, J.-C.; Müller, P.; Rosenkranz, S.; Böhm, M.

Source: European Journal of Clinical Investigation, Volume 39, Number 10, October 2009 , pp. 851-859(9)

Publisher: Blackwell Publishing

Fixed-Dose Combinations as Initial Therapy for Hypertension: A Review of Approved Agents and a Guide to Patient Selection

Authors: Waeber, Bernard; Feihl, François; Ruilope, Luis M.

Source: Drugs, Volume 69, Number 13, 10 September 2009 , pp. 1761-1776(16)

Publisher: Adis International

Role of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Hypertension in Patients Aged ≥65 Years

Author: Gradman, Alan H.

Source: Drugs & Aging, Volume 26, Number 9, 1 September 2009 , pp. 751-767(17)

Publisher: Adis International

One-Year Renal and Cardiac Effects of Bisoprolol versus Losartan in Recently Diagnosed Hypertensive Patients: A Randomized, Double-Blind Study

Authors: Parrinello, Gaspare; Paterna, Salvatore; Torres, Daniele; >Pietro Di Pasquale,; Mezzero, Manuela; >Gabriella La Rocca,; Cardillo, Mauro; Trapanese, Caterina; Caradonna, Mario; Licata, Giuseppe

Source: Clinical Drug Investigation, Volume 29, Number 9, 1 September 2009 , pp. 591-600(10)

Publisher: Adis International

Idiopathic Membranous Nephropathy: Management Strategies

Authors: Quaglia, Marco; Stratta, Piero

Source: Drugs, Volume 69, Number 10, 9 July 2009 , pp. 1303-1317(15)

Publisher: Adis International

Angiotensin II enhances the afferent arteriolar response to adenosine through increases in cytosolic calcium

Authors: Lai, E. Y.; Patzak, A.; Persson, A. E. G.; Carlström, M.

Source: Acta Physiologica, Volume 196, Number 4, August 2009 , pp. 435-445(11)

Publisher: Blackwell Publishing

Investigational vasopressin receptor modulators in the pipeline

Authors: Favory, Raphaël; Salgado, Diamantino R; Vincent, Jean-Louis

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 8, August 2009 , pp. 1119-1131(13)

Publisher: Informa Healthcare

The Myth of Janus: The Two Faces of Renal Outcomes in the ONTARGET Study

Author: Volpe, Massimo

Source: High Blood Pressure & Cardiovascular Prevention, Volume 16, Number 2, 2 June 2009 , pp. 35-37(3)

Publisher: Adis International

Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?

Authors: Burnier, Michel; Pruijm, Menno; Wuerzner, Gregoire

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 8, August 2009 , pp. 981-987(7)

Publisher: Informa Healthcare

Synergism of simvastatin with losartan prevents angiotensin II-induced cardiomyocyte apoptosis in vitro

Authors: Xu, Jian; Lü, Xiong-wen; Huang, Yan; Zhu, Peng-li; Li, Jun

Source: Journal of Pharmacy and Pharmacology, Volume 61, Number 4, April 2009 , pp. 503-510(8)

Publisher: Pharmaceutical Press

Persistent drug use provide economic benefits in DM

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 579, 2009-05-30 , pp. 10-10(1)

Publisher: Adis International

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A